Neil Wyant, Chairman of the Board of Directors
Mr. Wyant is the Managing Director of Everett Partners, Ltd., the venture investing arm of the Kanfer family and the Managing Director of Fir Hill, LLC, a venture services business. He also serves as a Director of Great Lakes Pharmaceuticals in Beachwood, Ohio. Mr. Wyant is also the Chairman of the Targetech Innovation Center, a technology incubator in Netanya, Israel. In addition he also serves as a member of the Ohio Venture Capital Task Force. Mr. Wyant is an experienced entrepreneur and commercialization expert. He has been involved with technology commercialization for over 25 years. His experience ranges from the protection of intellectual property, licensing, and new venture formation, to prototype demonstration and the sale of new products and services. Mr. Wyant has been a manager or advisor for companies in a variety of industries including advanced imaging, health services, alternative energy, and food technology. His work experience also includes over six years as a manager of the licensing and venturing arm of the University of Chicago where he was responsible for building and managing a portfolio of intellectual property for the University of Chicago and Argonne National Laboratory. Prior to his technology commercialization work, Mr. Wyant held various sales and marketing positions at a multi-national industrial gas company. Mr. Wyant holds BS degrees in chemical and biomedical engineering from Northwestern University and an MBA in marketing and finance from the University of Chicago.
Michael Marash, CEO and Director
Dr. Michael Marash is the founder and the CEO of the company. During the past 8 years, Dr. Marash led the company from the concept to the product commercialization. Under his leadership the company entered in collaboration with the major medical equipment providers such as Philips Medical Systems and others. His relationship in the field enabled to set partnership with strategically important healthcare providers and radiation oncology developers, significantly expending the company pipeline. Before P-Cure, Dr. Marash managed technology at Vecta Ltd, a biotech company, succeeding to bring several gastrointestinal and oncology products to the clinical development phases. Earlier, Dr. Marash was involved in the development of robotic image-guided diagnostic devices in several Hi-Tech companies. His professional experience is backed up with groundbreaking scientific accomplishments published in the most prestigious peer review journals. He's served in the Medical Troops in Israeli Defense Force and holds the MBA and the Ph.D. degrees from the Ben Gurion University and the Weizmann Institute of Science, respectively.
Elka Nir, Executive VP Business Development
Mrs. Nir served as a Managing Director and Head of Life Sciences at Giza Venture Capital. She also served as the Chief Operating Officer, as well as Development and Operations Manager at Biosense Webster, Inc. (Israel), Johnson & Johnson, leading a team of 150 people in the development and manufacture of state of the art medical electromagnetic navigation systems. Previously, Mrs. Nir served as Vice President of Research and Development and Vice President of Marketing for Medical Division at General Electric Company. She served as the Vice President of Engineering and Research and Development at General Electric Medical Systems, Israel, leading 100 researches and developing Nuclear Medicine systems. Mrs. Nir also served as a Vice President of Marketing, Sales & Customer Support at ELGEMS (GE & Elscint) and Product Manager at Elscint, Medical Imaging. She serves as chairperson and Director of several private and public medical device companies. Mrs Nir is a board director of the Israeli High Tech Association (IATI). She holds a B.Sc. degree in Computer Science from Technion-Israel's Institute of Technology and a degree Business Administration from the University of Haifa.
Leo Grunwald, Director
Mr. Grunwald is the senior partner of an accounting, audit and financial advisory practice in Toronto and founder and managing director of Lions Peak International Innovation Fund, a venture capital fund focusing on Israeli technology companies. He has comprehensive commercial and financial advisory experience, an extensive network of contacts, and outstanding access to institutions and investors in the United States, Europe, Canada and Israel. Since 1998, Mr. Grunwald has been directly involved in raising equity and forming strategic alliances for private and public companies in transactions valued at over $300 million. Mr. Grunwald is qualified as a Chartered Accountant in London, England in 1979. He relocated to Toronto and qualified as a Canadian Chartered Accountant in 1980.
Azriel Kadim, Director
Mr. Kadim has a history of business development in a variety of fields such as chemistry, materials, biotechnology, and life sciences. He served as the Chief Executive Officer of Orlite Industries Ltd, the major Israeli plastic supplier. He served as the Chief Executive Officer of the Poalim Investment Company, the investment arm of the major banking structure in Israel. Mr. Kadim, also managed technology licensing; in the position of a Director of Yeda Research and Development Company he took care of licensing and intellectual property protection for the Weizmann Institute of Science, one of the most prominent research institutions in the world. He has also managed the activities in Israel of AAI USA where he played a pivotal role in establishing a collaboration for development and supply of drones to the US Navy. For the past 15 years, Mr. Kadim managed Targetech Ltd, a national technological incubator, nurturing more then 20 Hi Tech ventures from their inception to the multi-million, global corporation stage. Mr. Kadim holds MS in Chemical Engineering from the Technion.